Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
NCT06611163
- Conditions
- Moderate to Severe Genital Psoriasis
- Locations
-
- Smary Cures Clinical Research Anaheim, California, United States
- California Dermatology & Clinical Research Institute Encinitas, California, United States
- T. Joseph Raoof MD, Inc./Encino Research Center Encino, California, United States
- Center for Dermatology Clinical Research, Inc Fremont, California, United States